Skip to main content

Advertisement

Table 3 Lipid profile changes of the Yerba Mate and placebo groups at 0, 6 and 12 weeks

From: Anti-obesity effects of Yerba Mate (Ilex Paraguariensis): a randomized, double-blind, placebo-controlled clinical trial

  Yerba Mate (n = 15) Placebo (n = 15) P value1)
  0 weeks 6 weeks 12 weeks P value1) 0 weeks 6 weeks 12 weeks P value1)
Total cholesterol (mg/dL) 193.6 ± 24.8 197.9 ± 33.2 204.4 ± 36.0 0.384 176.7 ± 28.8 172.3 ± 33.9 174.0 ± 28.4 0.977 0.722
HDL-cholesterol (mg/dL) 45.4 ± 7.7 48.0 ± 10.3 48.2 ± 10.1 0.424 52.3 ± 12.0 50.4 ± 8.3 48.0 ± 8.3 0.369 0.223
LDL-cholesterol (mg/dL) 120.9 ± 27.5 117.8 ± 28.8 121.7 ± 34.6 0.755 101.7 ± 25.6 97.2 ± 27.5 96.7 ± 30.8 0.944 0.862
Triglyceride (mg/dL) 141.5 ± 79.9 130.6 ± 96.3 154.2 ± 96.6 0.325 123.1 ± 65.8 107.2 ± 53.8 127.5 ± 95.1 0.548 0.969
Free Fatty Acid (μEq/L) 516.6 ± 163.6 412.2 ± 128.8 443.5 ± 169.7 0.234 541.5 ± 337.3 541.5 ± 225.6 575.3 ± 220.1 0.286 0.224
  1. Values are presented as the mean ± S.D
  2. 1) Analyzed by repeated measures ANOVA